Comment on a paper by Dupoiron et al. “A phase III randomized controlled study on the efficacy and improved bowel function of prolonged‐release (PR) oxycodone‐ naloxone (up to 160/80 mg daily) versus oxycodone PR”
Source: European Journal of Pain - Category: Anesthesiology Authors: Joanne Patel, Jennifer H. Martin, Catherine J. Lucas Tags: Letter to the Editor Source Type: research